|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
National Institute on Alcohol Abuse and Alcoholism (NIAAA) |
| Information provided by: | National Institute on Alcohol Abuse and Alcoholism (NIAAA) |
| ClinicalTrials.gov Identifier: | NCT00027053 |
Purpose
This study is a randomized, double-blind clinical trial comparing trazodone (Desyrel) and placebo among sleep-disturbed, alcohol-dependent individuals shortly after discharge from an inpatient detoxification program. Subjects will undergo a baseline assessment and random assignment to trazodone or identical placebo for 12 weeks. All persons completing the alcohol detoxification at Stanley Street Treatment and Resources (SSTAR) will be screened. (SSTAR of Rhode Island provides detoxification services to non/underinsured persons of Rhode Island.)
| Condition | Intervention | Phase |
|
Alcoholism |
Drug: trazodone (Desyrel) |
Phase II |
| MedlinePlus related topics: | Alcoholism Sleep Disorders |
| Drug Information available for: | Trazodone Trazodone hydrochloride Ethanol |
| Study Type: | Interventional |
| Study Design: | Treatment, Randomized, Double-Blind, Placebo Control, Efficacy Study |
| Official Title: | Trazodone for Sleep Disturbance - Early Alcohol Recovery |
Eligibility
| Ages Eligible for Study: | 18 Years to 65 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations
More Information
| Study ID Numbers: | NIAAAFRI13243, NIH grant R01 AA013243 |
| First Received: | November 19, 2001 |
| Last Updated: | March 3, 2006 |
| ClinicalTrials.gov Identifier: | NCT00027053 |
| Health Authority: | United States: Federal Government |
|
|
|
|
|